In the first of a two-part podcast, (https://www.trapelohealth.com/reimbursement-for-genetic-testing) Gabriel A. Bien-Willner MD, PhD, FCAP, Medical Director at MolDX, and Chief Medical Officer at Palmetto GBA shares how he has helped implement payer controls and coverage and set policies for affiliated Medicare Administrative Contractors in 28 states.
In the past, payers have had to navigate the growing field of precision medicine without the benefit of expertise, so their only guidance came from the NCCN or consultations with other experts in the field. Today, under his direction, Palmetto GBA is able to base its policies on evidentiary reviews, and he believes this form of evidence-based decision-making should be an industrywide standard.
Podden och tillhörande omslagsbild på den här sidan tillhör Trapelo. Innehållet i podden är skapat av Trapelo och inte av, eller tillsammans med, Poddtoppen.
